Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256476 · ClinicalTrials.gov registry record · Phase 4
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
A Phase 4 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 328
- Enrollment target
NCT01256476 is a Phase 4 study that has completed, run by Kowa Research Institute. The registered enrollment target is 328 participants.
The verdict
NCT01256476, a Phase 4 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 328 participants
- Enrollment target
Study Summary
Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.
Interventions
- DRUG pitavastatin
- DRUG pravastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256476
The ClinicalTrials.gov registry entry for NCT01256476 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pitavastatin is the first listed.
NCT01256476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01256476 about?
NCT01256476 is a clinical study titled "Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia". Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.
What is the current status of trial NCT01256476?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 328 participants. The study started on 2010-10. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01256476?
The interventions under investigation include: pitavastatin (DRUG), pravastatin (DRUG).
Who is sponsoring clinical trial NCT01256476?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.